StrokePhase 1rTMSNCT00913211
Repetitive Transcranial Magnetic Stimulation (rTMS) to Promote Hand Recovery in Stroke
A Phase 1 study testing rTMS, Motor learning training and rTMS and Tracking in people with Stroke, run by University of Minnesota at 1 site in United States.
Trial summary
Paralysis following stroke stems not only from the loss of neurons killed by the stroke but also from the loss of neurons lying dormant in the stroke hemisphere. One of the reasons viable neurons become dormant (down-regulated) is because of excessive interhemispheric inhibition imposed on them from the nonstroke… Read more about this study
- Who is it for?
- Ages 21 to 90 years
- Conditions the study is for
- Stroke
- What is being tested?
- rTMS, Motor learning training and rTMS and Tracking
- Type of treatment
- Medical device, Surgery or procedure
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- Sep 2007to Aug 2011
- Phase
- Phase 1
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Ischemic stroke at least 6 months prior, partial movement of paretic hand, ability to follow directions, ability to walk 100 feet, motor evoked response in stroke hemisphere during TMS
Who cannot join
- No history of seizures, no medical devices or metal incompatible with fMRI
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Minnesota
Minneapolis, Minnesota, 55455
About this study
Official title: rTMS and Motor Learning Training to Promote Recovery From Hemiparesis
Paralysis following stroke stems not only from the loss of neurons killed by the stroke but also from the loss of neurons lying dormant in the stroke hemisphere. One of the reasons viable neurons become dormant (down-regulated) is because of excessive interhemispheric inhibition imposed on them from the nonstroke hemisphere. The challenge in neurorehabilitation is to restore excitability and voluntary control of these down-regulated neurons in the stroke hemisphere. Suppression of the source of this excessive interhemispheric inhibition can be achieved with the noninvasive method called repetitive transcranial magnetic stimulation (rTMS). It has been shown in healthy subjects that the known depressant effects of low-frequency rTMS can be increased and prolonged by preceding it with 6-Hz priming stimulation. In a recent safety study, we showed that one treatment of 6-Hz primed low-frequency rTMS applied to the nonstroke hemisphere is safe. It is now important to evaluate a series of these treatments and whether their efficacy can be enhanced by combining the rTMS with motor learning training. The specific aims of this study are to determine the efficacy, mechanism, and safety of a series of 5 treatments of 6-Hz primed low-frequency rTMS applied to nonstroke hemisphere and combined with motor learning training to promote recovery of the paretic hand. Forty subjects with stroke will be randomly assigned to one of four treatment groups. The rTMS/only group will receive 20 min. of rTMS per day. The Track/only group will receive 20 min. of finger tracking training per day. The rTMS/combined group will receive alternating days of the rTMS and Track treatments. The rTMS/sham group will receive 20 min. of rTMS using a sham electrode each day. The hypotheses are: 1) the rTMS/combined group will show the greatest improvements in hand function, 2) the rTMS/combined group will show the greatest improvements in cortical excitability using paired-pulse TMS testing and in brain reorganization using fMRI, and 3) the rTMS treatment will be safe. The proposed research is important because it addresses the greatest cause of long-term disability in society, hemiparesis following stroke, and it is innovative because it applies a technique never used before, 6-Hz primed low-frequency rTMS combined with motor learning training. The potential impact of this research is a radical change to rehabilitation that accomplishes a higher quality of life in stroke.
Read the detailed description
The proposed research penetrates the problem of hemiparesis following stroke. This problem devastates quality of life in thousands of people each year. The brain shows remarkable ability to reorganize under certain conditions, including after stroke. Unfortunately, some changes are maladaptive and leave the individual with additional loss of function beyond that caused directly by the ischemic damage. Specifically, motor neurons in the ipsilesional (stroke) hemisphere that have survived the stroke can undergo a loss of excitability due to exaggerated interhemispheric inhibition imposed on them from neurons in the contralesional (non-stroke) hemisphere through transcallosal pathways. Fortunately, the maladaptive reorganization is reversible, even in chronic stroke, through forced-use and forced-learning paradigms with the paretic limb. But we postulate that the effectiveness of behavioral training can be richly enhanced when combined with electrophysiologic intervention that also affects neural excitability. Repetitive transcranial magnetic stimulation (rTMS) is a potent and noninvasive way to influence the excitability of the brain. rTMS, at low stimulation frequencies, depresses neural function. By stimulating the contralesional motor cortex at low frequency, thereby depressing interhemispheric inhibition, a net excitatory effect (disinhibition) is induced upon the ipsilesional motor cortex. Furthermore, it has been shown in animals and in healthy humans that the depressive effect on the stimulated hemisphere can be magnified by preceding the low-frequency rTMS with 6-hz "priming" rTMS. We will call this arrangement 6-Hz primed low-frequency rTMS. We contend that by combining 6-Hz primed low-frequency rTMS with behavioral motor learning training unprecedented improvements in recovery from hemiparesis can be achieved. We have recently demonstrated the safety of a single treatment of 6-Hz primed low-frequency rTMS in stroke but a large gap in knowledge still exists in not knowing the effect of serial treatments of 6-Hz primed low-frequency rTMS combined with motor learning training. Failure to address this gap only perpetuates the use of conservative strategies in stroke rehabilitation, which may rob individuals of their fullest possible recovery.
Our long-term goal is to maximize motor recovery following stroke. The objective of this proposal is to integrate the excitability effects induced exogenously by rTMS with those produced endogenously by motor learning to produce a powerful yet safe interactive effect leading to improved recovery from hemiparesis. The central hypothesis is that serial treatments of 6-Hz primed low-frequency rTMS combined with motor learning training will be effective and safe. Our research team is uniquely qualified to execute this project because of 1) special training in rTMS undertaken by the PI in the laboratory of an international leader in rTMS, 2) participation of this leader as a consultant, 3) participation of a neuroscientist with expertise in stroke neuroplasticity as a consultant, 4) participation of a recognized expert in cerebrovascular disease as a co-investigator, 5) conducting the study in the University of Minnesota's General Clinical Research Center to maximize protection of patients, and 6) inclusion of the Center for Magnetic Resonance Research for studying brain reorganization.
The specific aims of this project are to:
Specific Aim #1. Determine the efficacy of using serial treatments of 6-Hz primed low-frequency rTMS, in isolation and in combination with motor learning training, to improve hand function in stroke.
Forty subjects with stroke (with partial movement in weak hand, able to walk 100 feet, able to follow directions, no history of seizures, no medical devices or metal incompatible with mri) will be randomly assigned in equal numbers to one of four treatment groups: The rTMSonly group will receive 5 treatments of rTMS to the primary motor area (M1) of the contralesional hemisphere consisting of 10 min. of 6-Hz ("priming") rTMS at 90% of resting motor threshold interrupted into 20 trains of 5-s duration with 25-s intervals between trains then followed immediately by 10 additional min. of 1-Hz ("low-frequency") rTMS continuously at 90% of resting motor threshold. Treatments will be every other day over two weeks. The Trackonly group will receive 5 treatments of computerized finger tracking training every other day for two weeks. The rTMScombined group will receive the same rTMS as the rTMSonly group and it will be alternated with the same tracking training as the Trackonly group until 5 days of each have occurred over a two-week period. The rTMSsham group will receive the same rTMS procedures, including similar sound, but no magnetic stimulation will occur. The four treatments have a 2x2 factorial design, with rTMS and tracking as the factors, which allows estimation of any synergistic effects of rTMS combined with tracking. Behavioral gains in the paretic hand will be measured with finger prehension/dexterity tests, finger tracking accuracy, subject self ratings and examiner ratings. The working hypotheses are:
- the rTMScombined group will show greater improvements in paretic hand function than the rTMSonly and Trackonly groups at posttest and at one-month follow-up, and
- the rTMSonly and Trackonly groups will show greater improvements than the rTMSsham group.
Specific Aim #2. Explore the neural mechanism associated with 6-Hz primed low-frequency rTMS combined with tracking training.
Following the treatments described in Aim #1, M1 excitability will be measured with paired-pulse TMS testing in the ipsilesional hemisphere. This testing will allow for examination of both cortical inhibition and excitation. In addition, brain reorganization associated with voluntary activation will be measured with functional MRI yielding data on volume and signal intensity of active voxels during paretic finger tracking. The working hypotheses are:
- the rTMScombined group will show greater increases in cortical excitability and brain reorganization in the ipsilesional hemisphere than the rTMSonly and Trackonly groups at posttest and at one-month follow-up,
- the rTMSonly and Trackonly groups will show greater increases than the rTMSsham group.
Specific Aim #3. Determine the safety of serial 6-Hz primed low-frequency rTMS treatments in stroke.
Associated with the treatments described in Aim #1, adverse effects will be measured through observation for seizures at the time of treatment. Neurocognitive tests will measure mood, verbal comprehension, perceptual organization, working memory and processing speed. Also, a finger tracking test will measure motor control in the nonparetic hand. The working hypothesis is:
- five 6-Hz primed low-frequency rTMS treatments, given alone or in combination with motor learning training, will not produce any seizure activity or any other serious adverse effect.
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
rTMSDevice
600 pulses of 6 hz priming rTMS at 90% of threshold followed by 600 pulses of low-frequency rTMS at 90% of threshold.
Motor learning trainingProcedure or surgery
one hour of repeated finger tracking movements toward a changing target.
rTMS and TrackingProcedure or surgery
Combination of rTMS and finger tracking
Sham rTMSDevice
Sham treatment of rTMS
| Study group | Role | What they receive |
|---|---|---|
| rTMS only | Experimental | brain stimulation to non-stroke primary motor area Receives: Device: rTMS |
| Finger tracking training | Experimental | Motor learning training using finger flexion/extension tracking movements toward a target. Receives: Procedure: Motor learning training |
| rTMS and finger tracking | Experimental | Combination of rTMS and tracking Receives: Procedure: rTMS and Tracking |
| Sham | Placebo comparator | Sham rTMS treatment Receives: Device: Sham rTMS |
What is being measured
The primary outcome is the main question the study is designed to answer.
box and block finger prehension test
Measured: 45 days
Secondary outcomes (2)
cortical excitability
Paired pulse TMS testing will show increase in the ratio of paired pulse to single pulse MEP amplitude when stimulating ipsilesional M1.
Measured: from pretest to posttest (2 weeks)
cognitive function
There will be no decline in function on the Hopkins Verbal learning test.
Measured: pretest to posttest (2 weeks)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jun 2009 (estimated)
- Study startSep 2007
- Primary completionAug 2011
- Study completionAug 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- More trials run by University of MinnesotaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 1
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Minnesota
- Sponsor type
- University, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Responsible party
- Sponsor
- Investigators
- James R Carey, PhD, Principal investigator, University of Minnesota
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00913211
- Sponsor's protocol ID
- 0704M06701
- Other IDs
- 1R01HD053153-01A2
- Acronym
- rTMS
- Status last verified
- Aug 2011
- First submitted
- 2 Jun 2009
- Last updated
- 31 Aug 2011
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 31 Aug 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- rTMS and Motor Learning Training to Promote Recovery From Hemiparesis
- ClinicalTrials.gov ID
- NCT00913211
- Acronym / sponsor ID
- rTMS / 0704M06701
- Conditions
- Stroke
- Phase
- Phase 1
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- University of MinnesotaUniversity, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Study start
- Sep 2007
- Primary completion
- Aug 2011 (actual)
- Study completion
- Aug 2011 (actual)
- First posted
- 4 Jun 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Paralysis following stroke stems not only from the loss of neurons killed by the stroke but also from the loss of neurons lying dormant in the stroke hemisphere. One of the reasons viable neurons become dormant (down-regulated) is because of excessive interhemispheric inhibition imposed on them from the nonstroke hemisphere. The challenge in neurorehabilitation is to restore excitability and voluntary control of these down-regulated neurons in the stroke hemisphere. Suppression of the source of this excessive interhemispheric inhibition can be achieved with the noninvasive method called repetitive transcranial magnetic stimulation (rTMS). It has been shown in healthy subjects that the known depressant effects of low-frequency rTMS can be increased and prolonged by preceding it with 6-Hz priming stimulation. In a recent safety study, we showed that one treatment of 6-Hz primed low-frequency rTMS applied to the nonstroke hemisphere is safe. It is now important to evaluate a series of these treatments and whether their efficacy can be enhanced by combining the rTMS with motor learning training. The specific aims of this study are to determine the efficacy, mechanism, and safety of a series of 5 treatments of 6-Hz primed low-frequency rTMS applied to nonstroke hemisphere and combined with motor learning training to promote recovery of the paretic hand. Forty subjects with stroke will be randomly assigned to one of four treatment groups. The rTMS/only group will receive 20 min. of rTMS per day. The Track/only group will receive 20 min. of finger tracking training per day. The rTMS/combined group will receive alternating days of the rTMS and Track treatments. The rTMS/sham group will receive 20 min. of rTMS using a sham electrode each day. The hypotheses are: 1) the rTMS/combined group will show the greatest improvements in hand function, 2) the rTMS/combined group will show the greatest improvements in cortical excitability using paired-pulse TMS testing and in brain reorganization using fMRI, and 3) the rTMS treatment will be safe. The proposed research is important because it addresses the greatest cause of long-term disability in society, hemiparesis following stroke, and it is innovative because it applies a technique never used before, 6-Hz primed low-frequency rTMS combined with motor learning training. The potential impact of this research is a radical change to rehabilitation that accomplishes a higher quality of life in stroke.
Detailed description
The proposed research penetrates the problem of hemiparesis following stroke. This problem devastates quality of life in thousands of people each year. The brain shows remarkable ability to reorganize under certain conditions, including after stroke. Unfortunately, some changes are maladaptive and leave the individual with additional loss of function beyond that caused directly by the ischemic damage. Specifically, motor neurons in the ipsilesional (stroke) hemisphere that have survived the stroke can undergo a loss of excitability due to exaggerated interhemispheric inhibition imposed on them from neurons in the contralesional (non-stroke) hemisphere through transcallosal pathways. Fortunately, the maladaptive reorganization is reversible, even in chronic stroke, through forced-use and forced-learning paradigms with the paretic limb. But we postulate that the effectiveness of behavioral training can be richly enhanced when combined with electrophysiologic intervention that also affects neural excitability. Repetitive transcranial magnetic stimulation (rTMS) is a potent and noninvasive way to influence the excitability of the brain. rTMS, at low stimulation frequencies, depresses neural function. By stimulating the contralesional motor cortex at low frequency, thereby depressing interhemispheric inhibition, a net excitatory effect (disinhibition) is induced upon the ipsilesional motor cortex. Furthermore, it has been shown in animals and in healthy humans that the depressive effect on the stimulated hemisphere can be magnified by preceding the low-frequency rTMS with 6-hz "priming" rTMS. We will call this arrangement 6-Hz primed low-frequency rTMS. We contend that by combining 6-Hz primed low-frequency rTMS with behavioral motor learning training unprecedented improvements in recovery from hemiparesis can be achieved. We have recently demonstrated the safety of a single treatment of 6-Hz primed low-frequency rTMS in stroke but a large gap in knowledge still exists in not knowing the effect of serial treatments of 6-Hz primed low-frequency rTMS combined with motor learning training. Failure to address this gap only perpetuates the use of conservative strategies in stroke rehabilitation, which may rob individuals of their fullest possible recovery.
Our long-term goal is to maximize motor recovery following stroke. The objective of this proposal is to integrate the excitability effects induced exogenously by rTMS with those produced endogenously by motor learning to produce a powerful yet safe interactive effect leading to improved recovery from hemiparesis. The central hypothesis is that serial treatments of 6-Hz primed low-frequency rTMS combined with motor learning training will be effective and safe. Our research team is uniquely qualified to execute this project because of 1) special training in rTMS undertaken by the PI in the laboratory of an international leader in rTMS, 2) participation of this leader as a consultant, 3) participation of a neuroscientist with expertise in stroke neuroplasticity as a consultant, 4) participation of a recognized expert in cerebrovascular disease as a co-investigator, 5) conducting the study in the University of Minnesota's General Clinical Research Center to maximize protection of patients, and 6) inclusion of the Center for Magnetic Resonance Research for studying brain reorganization.
The specific aims of this project are to:
Specific Aim #1. Determine the efficacy of using serial treatments of 6-Hz primed low-frequency rTMS, in isolation and in combination with motor learning training, to improve hand function in stroke.
Forty subjects with stroke (with partial movement in weak hand, able to walk 100 feet, able to follow directions, no history of seizures, no medical devices or metal incompatible with mri) will be randomly assigned in equal numbers to one of four treatment groups: The rTMSonly group will receive 5 treatments of rTMS to the primary motor area (M1) of the contralesional hemisphere consisting of 10 min. of 6-Hz ("priming") rTMS at 90% of resting motor threshold interrupted into 20 trains of 5-s duration with 25-s intervals between trains then followed immediately by 10 additional min. of 1-Hz ("low-frequency") rTMS continuously at 90% of resting motor threshold. Treatments will be every other day over two weeks. The Trackonly group will receive 5 treatments of computerized finger tracking training every other day for two weeks. The rTMScombined group will receive the same rTMS as the rTMSonly group and it will be alternated with the same tracking training as the Trackonly group until 5 days of each have occurred over a two-week period. The rTMSsham group will receive the same rTMS procedures, including similar sound, but no magnetic stimulation will occur. The four treatments have a 2x2 factorial design, with rTMS and tracking as the factors, which allows estimation of any synergistic effects of rTMS combined with tracking. Behavioral gains in the paretic hand will be measured with finger prehension/dexterity tests, finger tracking accuracy, subject self ratings and examiner ratings. The working hypotheses are:
- the rTMScombined group will show greater improvements in paretic hand function than the rTMSonly and Trackonly groups at posttest and at one-month follow-up, and
- the rTMSonly and Trackonly groups will show greater improvements than the rTMSsham group.
Specific Aim #2. Explore the neural mechanism associated with 6-Hz primed low-frequency rTMS combined with tracking training.
Following the treatments described in Aim #1, M1 excitability will be measured with paired-pulse TMS testing in the ipsilesional hemisphere. This testing will allow for examination of both cortical inhibition and excitation. In addition, brain reorganization associated with voluntary activation will be measured with functional MRI yielding data on volume and signal intensity of active voxels during paretic finger tracking. The working hypotheses are:
- the rTMScombined group will show greater increases in cortical excitability and brain reorganization in the ipsilesional hemisphere than the rTMSonly and Trackonly groups at posttest and at one-month follow-up,
- the rTMSonly and Trackonly groups will show greater increases than the rTMSsham group.
Specific Aim #3. Determine the safety of serial 6-Hz primed low-frequency rTMS treatments in stroke.
Associated with the treatments described in Aim #1, adverse effects will be measured through observation for seizures at the time of treatment. Neurocognitive tests will measure mood, verbal comprehension, perceptual organization, working memory and processing speed. Also, a finger tracking test will measure motor control in the nonparetic hand. The working hypothesis is:
- five 6-Hz primed low-frequency rTMS treatments, given alone or in combination with motor learning training, will not produce any seizure activity or any other serious adverse effect.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| rTMS only | Experimental | Device: rTMSbrain stimulation to non-stroke primary motor area |
| Finger tracking training | Experimental | Procedure: Motor learning trainingMotor learning training using finger flexion/extension tracking movements toward a target. |
| rTMS and finger tracking | Experimental | Procedure: rTMS and TrackingCombination of rTMS and tracking |
| Sham | Placebo comparator | Device: Sham rTMSSham rTMS treatment |
Who may qualify
- Ages
- 21 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Ischemic stroke at least 6 months prior, partial movement of paretic hand, ability to follow directions, ability to walk 100 feet, motor evoked response in stroke hemisphere during TMS
Key exclusion criteria (1 listed)
- No history of seizures, no medical devices or metal incompatible with fMRI
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| rTMS600 pulses of 6 hz priming rTMS at 90% of threshold followed by 600 pulses of low-frequency rTMS at 90% of threshold. | Device | rTMS only |
| Motor learning trainingone hour of repeated finger tracking movements toward a changing target. | Procedure or surgery | Finger tracking training |
| rTMS and TrackingCombination of rTMS and finger tracking | Procedure or surgery | rTMS and finger tracking |
| Sham rTMSSham treatment of rTMS | Device | Sham |
Primary outcome
box and block finger prehension test
Time frame: 45 days
2 secondary outcomes
cortical excitability
Time frame: from pretest to posttest (2 weeks)
cognitive function
Time frame: pretest to posttest (2 weeks)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Aug 2011.
Related trials for Stroke
Active, not recruitingObservational study
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Hypertension, Diabetes
Active, not recruiting
Improving Visual Field Deficits With Noninvasive Brain Stimulation
Visual Field Defect, Peripheral, Stroke
Recruiting
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
Ischemic Stroke, Atrial Fibrillation
Active, not recruiting
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
Cardiovascular Diseases, Hypertension
RecruitingObservational study
Continuous Dual Aspiration Technique With Zoom System for Stroke
Ischemic Stroke, Acute Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
James R Carey, PhD principal investigator
University of Minnesota
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 1 study testing rTMS, Motor learning training and rTMS and Tracking in people with Stroke, run by University of Minnesota at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Aug 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
box and block finger prehension test (time frame: 45 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2011; AzTrials last refreshed its copy on 8 Nov 2026.